Publications by authors named "N Kuruca"

Article Synopsis
  • Crimean-Congo hemorrhagic fever (CCHF) is a severe viral disease with high mortality, linked to vascular issues caused by endothelial dysfunction.
  • This study assessed the impact of specific gene variants on CCHF risk among 101 individuals (51 patients and 50 healthy controls) using the PCR-RFLP method for genotyping.
  • Findings indicated a significant link between the 936 C > T genetic variant and an increased likelihood of developing CCHF, suggesting it could be a potential genetic marker for sensitivity to the disease in the Turkish population.
View Article and Find Full Text PDF

The coronavirus disease 2019 (COVID-19) is a recent pandemic occurring worldwide due to the (SARS-CoV-2) virus, spreading mainly through large respiratory droplets or maybe through other transmission routes. The human genome has the most varied immune response genes correlated with infectious diseases. Genetic variants of mannose-binding lectin 2 (), an immunomodulatory gene, were associated with the risk, severity, and frequency of viral infections.

View Article and Find Full Text PDF

The coronavirus disease 2019 (COVID-19) pandemic, which has caused a major global health crisis, primarily targets the upper and lower respiratory tract. But infected individuals may experience different clinical symptoms, ranging from asymptomatic to critical. The vitamin D receptor (VDR) and Toll-like receptor 2 (TLR2) polymorphisms play a role in the immune response.

View Article and Find Full Text PDF

Fibromyalgia syndrome (FMS), a chronic pain disorder of unknown etiology, is more common in women. This suggests that biological sex is important. Therefore, we performed an analysis to determine whether the progesterone receptor (P GR) gene Alu insertion (named P ROGINS) variant is associated with an increased risk of FMS in the Turkish population.

View Article and Find Full Text PDF

The most important complication of familial Mediterranean fever (FMF) is secondary amyloidosis. The aim of this study is to investigate the risk of developing FMF-related amyloidosis with macrophage migration inhibitory factor (MIF), interleukin 4 (IL-4), and IL-1 receptor antagonist (IL-1RA) variants. This study included 62 FMF patients with amyloidosis, 110 FMF patients without amyloidosis, and 120 controls.

View Article and Find Full Text PDF